Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
161.13 USD | +0.39% | +1.62% | -3.89% |
Fiscal Period: June | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 70.95B | 76.12B | 80.19B | 82.01B | 84.04B | |||||
Total Revenues | 70.95B | 76.12B | 80.19B | 82.01B | 84.04B | |||||
Cost of Goods Sold, Total | 34.64B | 36.97B | 41.98B | 42.6B | 40.6B | |||||
Gross Profit | 36.31B | 39.14B | 38.21B | 39.41B | 43.44B | |||||
Selling General & Admin Expenses, Total | 20.14B | 20.35B | 19.52B | 20.35B | 22.49B | |||||
Other Operating Expenses, Total | 20.14B | 20.35B | 19.52B | 20.35B | 22.49B | |||||
Operating Income | 16.17B | 18.79B | 18.69B | 19.06B | 20.95B | |||||
Interest Expense, Total | -465M | -502M | -439M | -756M | -925M | |||||
Interest And Investment Income | 155M | 45M | 51M | 307M | 473M | |||||
Net Interest Expenses | -310M | -457M | -388M | -449M | -452M | |||||
Other Non Operating Income (Expenses) | 772M | 71M | -8M | 83M | 271M | |||||
EBT, Excl. Unusual Items | 16.63B | 18.41B | 18.3B | 18.69B | 20.77B | |||||
Restructuring Charges | -782M | -330M | -253M | -329M | -658M | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 2M | 69M | -45M | - | - | |||||
Gain (Loss) On Sale Of Assets | -7M | - | - | - | - | |||||
Asset Writedown | - | - | - | - | -1.34B | |||||
Other Unusual Items | -13M | -531M | -5M | -9M | -7M | |||||
EBT, Incl. Unusual Items | 15.83B | 17.62B | 18B | 18.35B | 18.76B | |||||
Income Tax Expense | 2.73B | 3.26B | 3.2B | 3.62B | 3.79B | |||||
Earnings From Continuing Operations | 13.1B | 14.35B | 14.79B | 14.74B | 14.97B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 13.1B | 14.35B | 14.79B | 14.74B | 14.97B | |||||
Minority Interest | -76M | -46M | -51M | -85M | -95M | |||||
Net Income - (IS) | 13.03B | 14.31B | 14.74B | 14.65B | 14.88B | |||||
Preferred Dividend and Other Adjustments | 263M | 271M | 281M | 282M | 284M | |||||
Net Income to Common Incl Extra Items | 12.76B | 14.04B | 14.46B | 14.37B | 14.6B | |||||
Net Income to Common Excl. Extra Items | 12.76B | 14.04B | 14.46B | 14.37B | 14.6B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 5.13 | 5.69 | 6 | 6.07 | 6.18 | |||||
Basic EPS - Continuing Operations | 5.13 | 5.69 | 6 | 6.07 | 6.18 | |||||
Basic Weighted Average Shares Outstanding | 2.49B | 2.47B | 2.41B | 2.37B | 2.36B | |||||
Net EPS - Diluted | 4.96 | 5.5 | 5.81 | 5.9 | 6.02 | |||||
Diluted EPS - Continuing Operations | 4.96 | 5.5 | 5.81 | 5.9 | 6.02 | |||||
Diluted Weighted Average Shares Outstanding | 2.63B | 2.6B | 2.54B | 2.48B | 2.47B | |||||
Normalized Basic EPS | 4.15 | 4.65 | 4.72 | 4.9 | 5.46 | |||||
Normalized Diluted EPS | 3.93 | 4.41 | 4.48 | 4.67 | 5.21 | |||||
Dividend Per Share | 3.03 | 3.24 | 3.52 | 3.68 | 3.83 | |||||
Payout Ratio | 59.79 | 57.76 | 59.49 | 61.41 | 62.58 | |||||
American Depositary Receipts Ratio (ADR) | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | |||||
Supplemental Items | ||||||||||
EBITDA | 19.18B | 21.53B | 21.5B | 21.77B | 23.84B | |||||
EBITA | 16.53B | 19.11B | 19.01B | 19.38B | 21.29B | |||||
EBIT | 16.17B | 18.79B | 18.69B | 19.06B | 20.95B | |||||
EBITDAR | 19.53B | 21.85B | 21.81B | 22.08B | 24.19B | |||||
Effective Tax Rate - (Ratio) | 17.25 | 18.52 | 17.79 | 19.7 | 20.19 | |||||
Current Domestic Taxes | 1.56B | 1.99B | 2.27B | 2.66B | 2.32B | |||||
Current Foreign Taxes | 1.77B | 1.53B | 1.33B | 1.41B | 1.71B | |||||
Total Current Taxes | 3.33B | 3.52B | 3.6B | 4.07B | 4.03B | |||||
Total Deferred Taxes | -596M | -258M | -402M | -453M | -244M | |||||
Normalized Net Income | 10.32B | 11.46B | 11.39B | 11.6B | 12.88B | |||||
Non-Cash Pension Expense | -81M | -73M | -67M | 3M | 39M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 7.33B | 8.2B | 7.9B | 8B | 9.6B | |||||
Selling and Marketing Expenses | 7.33B | 8.2B | 7.9B | 8B | 9.6B | |||||
Research And Development Expense From Footnotes | 1.83B | 1.9B | 2B | 2B | 2B | |||||
Net Rental Expense, Total | 347M | 320M | 309M | 308M | 343M | |||||
Imputed Operating Lease Interest Expense | 39.29M | 37.55M | 33.32M | 55.02M | 72.29M | |||||
Imputed Operating Lease Depreciation | 308M | 282M | 276M | 253M | 271M | |||||
Stock-Based Comp., Other (Total) | 558M | 540M | 528M | 545M | 562M | |||||
Total Stock-Based Compensation | 558M | 540M | 528M | 545M | 562M |